Biobank for Inflammatory Chronic Diseases and Osteoporosis

Summary

The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.

Eligibility

Inclusion Criteria:

* Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
* With National Health Assurance
* Able to consent to the study

Exclusion Criteria:

* Pregnancy or breastfeeding
* Not able to give a consent
* Severe anemia (Hb\<10g/L)

Conditions5

Interventions1

Related trials

• Analysis of Circulating Tumor Markers in Blood — Institut du Cancer de Montpellier - Val d'Aurelle
• B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. — Poitiers University Hospital
• Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. — Hospices Civils de Lyon
• Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis — Assistance Publique - Hôpitaux de Paris
• Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer — Hospices Civils de Lyon
• Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases — University Hospital, Toulouse
• Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases — University Hospital, Toulouse
• DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls — Centre Hospitalier Universitaire Dijon

Browse More Trials